Passage of cell-penetrating peptides across a human epithelial cell layer in vitro

被引:103
作者
Lindgren, ME [1 ]
Hällbrink, MM [1 ]
Elmquist, AM [1 ]
Langel, Ü [1 ]
机构
[1] Univ Stockholm, Dept Neurochem & Neurotoxicol, S-10691 Stockholm, Sweden
关键词
cell-penetrating peptide; drug delivery; epithelial barrier; penetratin; transcellular delivery; transportan;
D O I
10.1042/BJ20030760
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell barriers are essential for the maintenance and regulation of the microenvironments of the human body. Cell-penetrating peptides have simplified the delivery of bioactive cargoes across the plasma membrane. Here, the passage of three cell-penetrating peptides (transportan, the transportan analogue transportan 10, and penetratin) across a Caco-2 human colon cancer cell layer in vitro was investigated. The peptides were internalized into epithelial Caco-2 cells as visualized by indirect fluorescence microscopy and quantified by fluorimetry. Studies of peptide outflow from cells showed that the peptides were in equilibrium across the plasma membrane. The ability of the peptides to cross a Caco-2 cell layer was tested in a two-chambered model system. After 120 min, 7.0 %, 2.8 % and 0.6 % of added transportan, transportan 10 and penetratin respectively was detected in the lower chamber. Both transportan and transportan 10 reversibly decreased the traps-epithelial electrical resistance of the barrier model, with minimum values after 60 min of 46 % and 60 % of control respectively. Penetratin did not affect the resistance of the cell layer to the same extent. Although transportan markedly increased the passage of ions, the paracellular flux of 4.4 kDa fluorescein-labelled dextran was limited. In conclusion, the results indicate that the transportan peptides pass the epithelial cell layer mainly by a mechanism involving a transcellular pathway.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 31 条
  • [1] Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126
  • [2] Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996)
    Artursson, P
    Palm, K
    Luthman, K
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) : 27 - 43
  • [3] How structural features influence the biomembrane permeability of peptides
    Burton, PS
    Conradi, RA
    Ho, NFH
    Hilgers, AR
    Borchardt, RT
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (12) : 1336 - 1340
  • [4] Tryptophan fluorescence study of the interaction of penetratin peptides with model membranes
    Christiaens, B
    Symoens, S
    Vanderheyden, S
    Engelborghs, Y
    Joliot, A
    Prochiantz, A
    Vandekerckhove, J
    Rosseneu, M
    Vanloo, B
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (12): : 2918 - 2926
  • [5] Trojan peptides: the penetratin system for intracellular delivery
    Derossi, D
    Chassaing, G
    Prochiantz, A
    [J]. TRENDS IN CELL BIOLOGY, 1998, 8 (02) : 84 - 87
  • [6] VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions
    Elmquist, A
    Lindgren, M
    Bartfai, T
    Langel, U
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 269 (02) : 237 - 244
  • [7] Cargo delivery kinetics of cell-penetrating peptides
    Hällbrink, M
    Florén, A
    Elmquist, A
    Pooga, M
    Bartfai, T
    Langel, Ü
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1515 (02): : 101 - 109
  • [8] JOLIOT AH, 1991, NEW BIOL, V3, P1121
  • [9] A galanin-mastoparan chimeric peptide activates the Na+,K+-ATPase and reverses its inhibition by ouabain
    Langel, U
    Pooga, M
    Kairane, C
    Zilmer, M
    Bartfai, T
    [J]. REGULATORY PEPTIDES, 1996, 62 (01) : 47 - 52
  • [10] LANGEL U, 2002, CELL PENETRATING PEP, V1